IFNA1 and hepatocellular carcinoma: Cumulative HCC development rates were similar between PEG-IFN/RBV and DCV/ASV groups both in patients with FIB4 index of <3.25 (P = 0.796) and ≥3.25 (P = 0.675) (Fig 2B).